Memorial Sloan-Kettering Cancer Center

Interviews and expert commentary tagged “Memorial Sloan-Kettering Cancer Center” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

Mark A Dickson, ASCO 2026: Abemaciclib Brings Marked Increase in Progression Free Survival for Patients with Advanced Dedifferentiated Liposarcoma
Audio Journal of Oncology

Mark A Dickson, ASCO 2026: Abemaciclib Brings Marked Increase in Progression Free Survival for Patients with Advanced Dedifferentiated Liposarcoma

Abemaciclib Brings Marked Increase in Progression Free Survival for Patients with Advanced Dedifferentiated Liposarcoma An interview with: Mark A Dickson MD, Medical Oncologist, Associate Attending Ph

15 June 2026
7:24
Clear-cell renal cell cancer: first molecular prognostic marker also brings scope for drug targeting
Audio Journal of Oncology

Clear-cell renal cell cancer: first molecular prognostic marker also brings scope for drug targeting

SAN FRANCISCO— A recently discovered molecular prognostic biomarker for clear-cell renal cell cancer has been validated and shown to indicate a four-fold increase in risk of adverse cancer-specific su

27 February 2014
0:00